Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Artemisinin and partner drug-resistant falciparum malaria is expanding over the Greater Mekong Sub-region (GMS). Eliminating falciparum malaria in the GMS while drugs still retain enough efficacy could prevent global spread of antimalarial resistance. Eliminating malaria rapidly requires targeting the reservoir of asymptomatic parasite carriers. This pilot trial aimed to evaluate the acceptability, safety, feasibility and effectiveness of mass-drug administration (MDA) in reducing malaria in four villages in Eastern Myanmar. Methods: Villages with ≥30% malaria prevalence were selected. Long-lasting insecticidal bednets (LLINs) and access to malaria early diagnosis and treatment (EDT) were provided. Two villages received MDA immediately and two were followed for nine months pre-MDA. MDA consisted of a 3-day supervised course of dihydroartemisinin-piperaquine and single low-dose primaquine administered monthly for three months. Adverse events (AE) were monitored by interviews and consultations. Malaria prevalence was assessed by ultrasensitive PCR quarterly for 24 months. Symptomatic malaria incidence,entomological indices, and antimalarial resistance markers were monitored. Results: MDA was well tolerated. There were no serious AE and mild to moderate AE were reported in 5.6%(212/3931) interviews. In the smaller villages, participation to three MDA courses was 61% and 57%, compared to 28% and 29% in the larger villages. Baseline prevalence was higher in intervention than in control villages (18.7% (95%CI=16.1-21.6) versus 6.8%(5.2-8.7), p<0.0001) whereas three months after starting MDA, prevalence was lower in intervention villages (0.4%(0.04-1.3) versus 2.7%(1.7-4.1), p=0.0014). After nine months the difference was no longer significant (2.0%(1.0-3.5) versus 0.9%(0.04-1.8), p=0.10). M0-M9 symptomatic falciparum incidence was similar between intervention and control. Before/after MDA comparisons showed that asymptomatic P. falciparum carriage and anopheline vector positivity decreased significantly whereas prevalence of the artemisinin-resistance molecular marker remained stable. Conclusions: This MDA was safe and feasible, and, could accelerate elimination of P. falciparum in addition to EDT and LLINs when community participation was sufficient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., Sreng, S., Anderson, J. M., Mao, S., Sam, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314981 · Cited by 2,205 · cited 5×
“Infection of primary malaria vectors (Anopheles minimus s.l., An. maculatus s.l., and An. dirus s.l.) by plasmodium parasites was determined using a quantitative real-time PCR (qPCR) assay, confirmed with a second assay amplifying a different DNA target25.”
BackgroundInfluentialSelf-citationCarrara, V. I., Lwin, K. M., Phyo, A. P., Ashley, E., Wiladphaingern, J., Sriprawat, K., Rijken, M., Boel, M., McGready, R., Proux, S., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001398 · Cited by 185 · cited 2×
“Population during MDA period and MDA coverage: n (%) Present at least once during the 3 MDA months 386 (100) 662 (100) 367 (100) 977 (100) Present continuously during 3 MDA months 280 (73) 488 (74) 283 (77) 618 (63) Taking 0 round of MDA 26 (7) 175 (26) 28 (8) 297 (30) Taking 1 round of MDA 60 (16) 180 (27) 64 (17) 22…”
Self-citationThe role of early detection and treatment in malaria elimination
Landier, J., Parker, D. M., Thu, A. M., Carrara, V. I., Lwin, K. M., Bonnington, C. A., Pukrittayakamee, S., Delmas, G., & Nosten, F. H. (2016) · Malaria Journal · doi:10.1186/s12936-016-1399-y · Cited by 170 · cited 1×
“Population during MDA period and MDA coverage: n (%) Present at least once during the 3 MDA months 386 (100) 662 (100) 367 (100) 977 (100) Present continuously during 3 MDA months 280 (73) 488 (74) 283 (77) 618 (63) Taking 0 round of MDA 26 (7) 175 (26) 28 (8) 297 (30) Taking 1 round of MDA 60 (16) 180 (27) 64 (17) 22…”
Self-citationCarrara, V. I., Sirilak, S., Thonglairuam, J., Rojanawatsirivet, C., Proux, S., Gilbos, V., Brockman, A., Ashley, E. A., McGready, R., Krudsood, S., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030183 · Cited by 146
Self-citationCommunity engagement on the Thai-Burmese border: rationale, experience and lessons learnt.
Cheah, P. Y., Lwin, K. M., Phaiphun, L., Maelankiri, L., Parker, M., Day, N. P., White, N. J., & Nosten, F. (2010) · International Health · doi:10.1016/j.inhe.2010.02.001 · Cited by 80
Self-citation
Cited by
Ashley, E. A., Pyae Phyo, A., & Woodrow, C. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30324-6 · Cited by 553
Parker, D. M., Landier, J., Thu, A. M., Lwin, K. M., Delmas, G., Nosten, F. H., & The Malaria Elimination Task Force Group (2017) · Wellcome Open Research · doi:10.12688/wellcomeopenres.12741.1 · Cited by 13
Self-citation
Metadata
- Authors
- Landier, J., Kajeechiwa, L., Thwin, M. M., Parker, D. M., Chaumeau, V., Wiladphaingern, J., Imwong, M., Miotto, O., Patumrat, K., Duanguppama, J., Cerqueira, D., Malleret, B., Rénia, L., Nosten, S., von Seidlein, L., Ling, C., Proux, S., Corbel, V., Simpson, J. A., Dondorp, A. M., White, N. J., & Nosten, F. H.
- Venue
- Wellcome Open Research
- Publisher
- F1000 Research Ltd
- Published
- 2017-09-06
- Volume
- 2
- Pages
- 81
- ISSN
- 2398-502X (ISSN-L)
- OpenAlex
- W2751699411
- Cited by
- 87
- References
- 5
- FWCI
- 11.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. https://app.cochat.ai/papers/10.12688/wellcomeopenres.12240.1
- The paper
- Landier, J., Kajeechiwa, L., Thwin, M. M., Parker, D. M., Chaumeau, V., Wiladphaingern, J., Imwong, M., Miotto, O., Patumrat, K., Duanguppama, J., Cerqueira, D., Malleret, B., Rénia, L., Nosten, S., von Seidlein, L., Ling, C., Proux, S., Corbel, V., Simpson, J. A., . . . Nosten, F. H. (2017). Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: A pilot trial in four villages of Eastern Myanmar. Wellcome Open Research. https://doi.org/10.12688/wellcomeopenres.12240.1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.